The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Cirrhosis reversal: a duel between dogma and myth
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 2×
“Liver tissue hypoxia aggravates fibrosis progression, so that fibrosis and hypoxia may aggravate each other in the presence of persistent parenchymal injury, leading to a vicious circle, which disrupts the normal tissue repair and hereby promotes the development and progression of cirrhosis [19,33], with its lower deg…”
BackgroundLiver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075 · cited 2×
“Several recent reviews give brilliant synopses of the progress in this field [41–45], including the role of hepatic stellate cell apoptosis in the resolution of fibrosis [46,47].”
BackgroundCapillarization of hepatic sinusoids in man
Schaffner, F., & Popper, H. (1963) · Gastroenterology · doi:10.1016/s0016-5085(63)80130-4 · Cited by 610
Hnf4: A Central Regulator of Hepatocyte Differentiation and Function
Watt, A. J., Garrison, W. D., & Duncan, S. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50273 · Cited by 307
Cited by
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
Sarin, S. K., Kedarisetty, C. K., Abbas, Z., Amarapurkar, D., Bihari, C., Chan, A. C. Y., Chawla, Y. K., Dokmeci, A. K., Garg, H., Ghazinyan, H., et al. (2014) · Hepatology International · doi:10.1007/s12072-014-9580-2 · Cited by 1,481
“The degree of hepatic fibrosis and the functional hepatocellular mass remains heterogeneous in patients with the chronic hepatitis [32, 33].”
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
APASL ACLF Research Consortium (AARC) for APASL ACLF working Party., Sarin, S. K., Choudhury, A., Sharma, M. K., Maiwall, R., Al Mahtab, M., Rahman, S., Saigal, S., Saraf, N., Soin, A. S., et al. (2019) · Hepatology International · doi:10.1007/s12072-019-09946-3 · Cited by 884
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866
Gressner, A. M., & Weiskirchen, R. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00292.x · Cited by 718
Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications
Friedman, S. L. (2004) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0055 · Cited by 498
Mechanisms of liver fibrosis and its role in liver cancer
Dhar, D., Baglieri, J., Kisseleva, T., & Brenner, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219898141 · Cited by 429
Redox mechanisms in hepatic chronic wound healing and fibrogenesis
Novo, E., & Parola, M. (2008) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-1-5 · Cited by 406
Reversal of Hepatic Fibrosis — Fact or Fantasy?
Friedman, S. L., & Bansal, M. B. (2006) · Hepatology · doi:10.1002/hep.20974 · Cited by 379
Fibrosis and alcohol-related liver disease
Lackner, C., & Tiniakos, D. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.003 · Cited by 322
Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C
Mallet, V., Gilgenkrantz, H., Serpaggi, J., Verkarre, V., Vallet-Pichard, A., Fontaine, H., & Pol, S. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-6-200809160-00006 · Cited by 299
Karsdal, M. A., Nielsen, M. J., Sand, J. M., Henriksen, K., Genovese, F., Bay-Jensen, A.-C., Smith, V., Adamkewicz, J. I., Christiansen, C., & Leeming, D. J. (2013) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2012.474 · Cited by 279
Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
Caligiuri, A., Gentilini, A., Pastore, M., Gitto, S., & Marra, F. (2021) · Cells · doi:10.3390/cells10102759 · Cited by 270
Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation
Iredale, J. P., Thompson, A., & Henderson, N. C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.002 · Cited by 269
Fibrosis in chronic liver diseases: diagnosis and management
Pinzani, M., Rombouts, K., & Colagrande, S. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.008 · Cited by 267
Powell, L. W., Seckington, R. C., & Deugnier, Y. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01315-x · Cited by 266
Thabut, D., & Shah, V. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.07.004 · Cited by 266
Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study
Katoonizadeh, A., Laleman, W., Verslype, C., Wilmer, A., Maleux, G., Roskams, T., & Nevens, F. (2010) · Gut · doi:10.1136/gut.2009.189639 · Cited by 252
Self-citationPatsenker, E., Popov, Y., Stickel, F., Schneider, V., Ledermann, M., Sägesser, H., Niedobitek, G., Goodman, S. L., & Schuppan, D. (2009) · Hepatology · doi:10.1002/hep.23144 · Cited by 174
Popov, Y., Sverdlov, D. Y., Bhaskar, K. R., Sharma, A. K., Millonig, G., Patsenker, E., Krahenbuhl, S., Krahenbuhl, L., & Schuppan, D. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00394.2009 · Cited by 136
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach
Brennan, P. N., Elsharkawy, A. M., Kendall, T. J., Loomba, R., Mann, D. A., & Fallowfield, J. A. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00796-x · Cited by 68
Liu, F., Liu, Z.-D., Wu, N., Cong, X., Fei, R., Chen, H.-S., & Wei, L. (2009) · Liver Transplantation · doi:10.1002/lt.21845 · Cited by 43
“Liver fibrosis results from an imbalance in the normal wound-healing response resulting in an abnormal continuation of fibrogenesis (connective tissue production and deposition).(1) The most common causes of liver fibrosis are infection with the hepatitis B or C virus, autoimmune diseases, and metabolic disorders, but…”
BackgroundRegression of HCV cirrhosis: Time will tell
Garcia‐Tsao, G. (2018) · Hepatology · doi:10.1002/hep.29720 · Cited by 15
“Because cirrhosis regression is not only about fibrosis regression but also about reversal of vascular and parenchymal abnormalities which are not assessed by the METAVIR score and could be irreversible (10, 11), the best evidence and definition of regression of cirrhosis will be based on the assessment of long-term c…”
BackgroundFuture mechanistic strategies for tackling fibrosis–an unmet need in liver disease
Fallowfield, J. A. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-6-s83 · Cited by 15
Bone Marrow Stromal Cells Control the Growth of Hepatic Stellate Cells in vitro
Shi, L., Li, G., Wang, J., Sun, B., Yang, L., Wang, G., Wang, D., Mu, L., Chen, H., Jin, L., et al. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0227-9 · Cited by 7
Metadata
- Authors
- Desmet, V. J., & Roskams, T.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 40
- Issue
- 5
- Pages
- 860-867
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1983086656
- Cited by
- 247
- References
- 5
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.